Position in IRWD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$419,004
+$70,318 QoQ
Shares Held
99,526
+0.2% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 212 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. IRWD ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
18,815,747 | $298,794,060 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
502,267 | $84,652,078 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
619,298 | $68,704,917 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
123,215 | $66,761,581 | |
| 5 | ZTS |
Zoetis Inc.
|
812,181 | $58,363,324 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,396,427 | $34,366,066 | |
| 7 | ALKS |
Alkermes plc.
|
630,325 | $33,029,029 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,581,869 | $27,382,151 |
All Filings in IRWD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $419,004 | 99,526 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $348,686 | 99,341 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $404,295 | 119,969 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $157,159 | 119,969 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $34,651 | 48,127 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $72,942 | 49,621 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,505,687 | 565,618 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,464,591 | 598,202 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,161,891 | 638,327 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,334,064 | 612,407 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,003,828 | 787,048 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,866,103 | 712,991 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,326,798 | 594,624 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,640,928 | 631,267 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $7,522,464 | 607,140 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,962,863 | 575,566 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,068,132 | 613,021 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $365,825 | 29,080 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $428,563 | 36,755 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $846,718 | 64,833 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $459,265 | 35,685 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $415,380 | 37,154 | Shares | Defined | 2021-05-17 | |
| 2020-03-31 | $604,481 | 59,909 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||